MK2866 - Deus Medical

Ostarine, scientifically known as "Enobosarm" or "MK-2866", was first developed in the early 2000s, with a patent in 2001 by The University of Tennessee Research Corporation. GTx Inc. took over in partnering with Merck in 2007. Is is a SARM that targets androgen receptors in muscle and bone, enhancing muscle mass and reducing fat without the strong androgenic effects of anabolic steroids. Popular in fitness for its muscle-preserving effects, also been studied for medical applications, including muscle wasting from cancer, though its clinical success has been mixed.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about MK2866 by Deus Medical, consult with your doctor or healthcare professional.